AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Citadel Group

Major Shareholding Notification Dec 9, 2025

10454_rns_2025-12-09_c6528bcd-db6b-47d0-9fdb-90029986e4c3.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8672K

Citadel Group

09 December 2025

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree
AVADEL PHARMACEUTICALS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) N/A
(e)   Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure
8 December 2025
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"
N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security

(Note 3)
Common Stock ISIN IE00BDGMC594

$0.01 ordinary shares
Interests Short positions
Number % Number %
(1)   Relevant securities owned and/or controlled 979,986 0.99 246,400 0.25
(2)   Cash-settled derivatives 0 0.00 0 0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell 199,100 0.20 794,500 0.80
Total 1,179,086 1.20 1,040,900 1.06

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant

security
Purchase/sale Number of

securities
Price per unit

(Note 5)
Common Buy Transaction 229 21.3000 USD
Common Buy Transaction 300 21.3050 USD
Common Buy Transaction 1,692 21.3100 USD
Common Buy Transaction 9,630 21.3101 USD
Common Buy Transaction 370 21.3110 USD
Common Buy Transaction 297 21.3186 USD
Common Buy Transaction 2,433 21.3200 USD
Common Buy Transaction 5 21.3220 USD
Common Buy Transaction 700 21.3229 USD
Common Buy Transaction 11 21.3245 USD
Common Buy Transaction 200 21.3251 USD
Common Buy Transaction 13,562 21.3265 USD
Common Buy Transaction 2,065 21.3271 USD
Common Buy Transaction 140 21.3279 USD
Common Buy Transaction 362 21.3283 USD
Common Buy Transaction 1,700 21.3288 USD
Common Buy Transaction 1,000 21.3290 USD
Common Buy Transaction 4,401 21.3300 USD
Common Buy Transaction 1,600 21.3303 USD
Common Buy Transaction 116 21.3315 USD
Common Buy Transaction 179 21.3326 USD
Common Buy Transaction 47 21.3336 USD
Common Buy Transaction 12 21.3350 USD
Common Buy Transaction 981 21.3400 USD
Common Buy Transaction 51 21.3431 USD
Common Buy Transaction 2,354 21.3434 USD
Common Buy Transaction 1,677 21.3500 USD
Common Buy Transaction 474 21.3544 USD
Common Buy Transaction 330 21.3550 USD
Common Buy Transaction 100 21.3600 USD
Common Sell Transaction 3 21.3000 USD
Common Sell Transaction 117 21.3050 USD
Common Sell Transaction 475 21.3059 USD
Common Sell Transaction 179 21.3093 USD
Common Sell Transaction 9,801 21.3100 USD
Common Sell Transaction 370 21.3110 USD
Common Sell Transaction 702 21.3136 USD
Common Sell Transaction 79 21.3150 USD
Common Sell Transaction 302 21.3166 USD
Common Sell Transaction 920 21.3172 USD
Common Sell Transaction 5,693 21.3200 USD
Common Sell Transaction 685 21.3247 USD
Common Sell Transaction 916 21.3250 USD
Common Sell Transaction 2,000 21.3250 USD
Common Sell Transaction 70 21.3251 USD
Common Sell Transaction 947 21.3258 USD
Common Sell Transaction 13,570 21.3261 USD
Common Sell Transaction 7 21.3286 USD
Common Sell Transaction 800 21.3287 USD
Common Sell Transaction 4,000 21.3300 USD
Common Sell Transaction 3,328 21.3307 USD
Common Sell Transaction 110 21.3309 USD
Common Sell Transaction 684 21.3329 USD
Common Sell Transaction 351 21.3343 USD
Common Sell Transaction 500 21.3345 USD
Common Sell Transaction 100 21.3350 USD
Common Sell Transaction 85 21.3352 USD
Common Sell Transaction 694 21.3364 USD
Common Sell Transaction 470 21.3379 USD
Common Sell Transaction 6 21.3383 USD
Common Sell Transaction 1,829 21.3385 USD
Common Sell Transaction 14 21.3393 USD
Common Sell Transaction 865 21.3400 USD
Common Sell Transaction 2,607 21.3400 USD
Common Sell Transaction 381 21.3500 USD

Ap29

(b)           Cash-settled derivative transactions

Class of

relevant

security
Product

description

e.g. CFD
Nature of dealing

e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of

reference

securities

(Note 6)
Price

per unit

(Note 5)

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of

relevant

security
Product

description e.g. call

option
Writing, purchasing, selling, varying

etc.
Number

of

securities

to which

option

relates

(Note 6)
Exercise

price per

unit
Type

e.g.

American,

European

etc.
Expiry

date
Option

money

paid/

received per unit
Common Call Option Buy Transaction 100 15.0000 USD American 2026-01-16 6.3400 USD
Common Call Option Buy Transaction 2,700 7.5000 USD American 2027-01-15 13.8000 USD
Common Call Option Sell Transaction 20,000 22.5000 USD American 2026-01-16 0.0500 USD
Common Call Option Sell Transaction 500 17.5000 USD American 2025-12-19 3.8400 USD
Common Call Option Sell Transaction 500 17.5000 USD American 2025-12-19 3.9000 USD

(ii)           Exercise

Class of

relevant

security
Product

description

e.g. call

option
Exercising/

exercised

against
Number of

securities
Exercise

price per

unit

(Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of

relevant

security
Nature of dealing

e.g. subscription,

conversion, exercise
Details Price per unit (if

applicable)

(Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached? YES
Date of disclosure 9 December 2025
Contact name Paula Santos
Telephone number 020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1.             KEY INFORMATION

Full name of person making

disclosure:
Citadel Group
Name of offeror/offeree in relation

to whose relevant securities the

disclosure relates:
AVADEL PHARMACEUTICALS PLC

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of

relevant

security
Product

description

e.g. call

option
Written or

purchased
Number of

securities to

which option

or derivative

relates
Exercise

price

per unit
Type

e.g.

American,

European

etc.
Expiry

date
Common Put Option Purchased -4,700 15.0 USD American 19/12/2025
Common Put Option Purchased -44,400 10.0 USD American 16/01/2026
Common Call Option Purchased 24,200 22.5 USD American 20/03/2026
Common Call Option Purchased 900 7.5 USD American 19/12/2025
Common Put Option Purchased -3,100 12.5 USD American 20/03/2026
Common Put Option Purchased -100 20.0 USD American 18/06/2026
Common Call Option Purchased 4,200 17.5 USD American 16/01/2026
Common Call Option Purchased 5,600 12.5 USD American 15/01/2027
Common Put Option Purchased -1,000 17.5 USD American 18/06/2026
Common Put Option Purchased 0 10.0 USD American 20/03/2026
Common Call Option Purchased 5,100 15.0 USD American 15/01/2027
Common Put Option Purchased -100 7.5 USD American 20/03/2026
Common Put Option Purchased -2,900 7.5 USD American 19/12/2025
Common Put Option Purchased -60,700 15.0 USD American 16/01/2026
Common Call Option Purchased 37,600 20.0 USD American 19/12/2025
Common Put Option Purchased -100 15.0 USD American 15/01/2027
Common Call Option Purchased 2,200 20.0 USD American 18/06/2026
Common Put Option Purchased -900 25.0 USD American 20/03/2026
Common Call Option Purchased 3,000 25.0 USD American 15/01/2027
Common Call Option Purchased 0 5.0 USD American 16/01/2026
Common Put Option Purchased -3,800 15.0 USD American 20/03/2026
Common Put Option Purchased -200 17.5 USD American 20/03/2026
Common Call Option Purchased 0 25.0 USD American 20/03/2026
Common Call Option Purchased 5,100 22.5 USD American 15/01/2027
Common Put Option Purchased 0 12.5 USD American 15/01/2027
Common Put Option Sold 300 20.0 USD American 20/03/2026
Common Call Option Sold -2,100 12.5 USD American 20/03/2026
Common Put Option Sold 24,900 7.5 USD American 16/01/2026
Common Call Option Sold -7,500 7.5 USD American 15/01/2027
Common Put Option Sold 4,400 17.5 USD American 16/01/2026
Common Call Option Sold -65,900 12.5 USD American 16/01/2026
Common Put Option Sold 1,600 12.5 USD American 19/12/2025
Common Call Option Sold -9,600 7.5 USD American 16/01/2026
Common Call Option Sold -13,400 10.0 USD American 15/01/2027
Common Call Option Sold -5,100 10.0 USD American 19/12/2025
Common Call Option Sold -30,000 15.0 USD American 20/03/2026
Common Put Option Sold 2,000 17.5 USD American 19/12/2025
Common Put Option Sold 59,000 5.0 USD American 16/01/2026
Common Put Option Sold 8,200 10.0 USD American 19/12/2025
Common Call Option Sold -100 30.0 USD American 19/12/2025
Common Call Option Sold -147,700 15.0 USD American 16/01/2026
Common Call Option Sold -100 35.0 USD American 16/01/2026
Common Call Option Sold -100 20.0 USD American 15/01/2027
Common Call Option Sold -34,200 5.0 USD American 15/01/2027
Common Call Option Sold -20,800 17.5 USD American 19/12/2025
Common Call Option Sold -46,200 20.0 USD American 16/01/2026
Common Call Option Sold -4,900 22.5 USD American 19/12/2025
Common Call Option Sold -6,800 25.0 USD American 19/12/2025
Common Call Option Sold -38,000 15.0 USD American 19/12/2025
Common Call Option Sold -2,600 30.0 USD American 16/01/2026
Common Put Option Sold 5,300 20.0 USD American 19/12/2025
Common Put Option Sold 5,500 12.5 USD American 16/01/2026
Common Call Option Sold -5,400 20.0 USD American 20/03/2026
Common Call Option Sold -4,800 17.5 USD American 15/01/2027
Common Call Option Sold -179,400 10.0 USD American 16/01/2026
Common Call Option Sold -6,200 12.5 USD American 19/12/2025
Common Call Option Sold -29,900 22.5 USD American 16/01/2026
Common Call Option Sold -1,700 25.0 USD American 16/01/2026
Common Call Option Sold -10,000 17.5 USD American 20/03/2026

3.             AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPTLBTTMTTMBJA

Talk to a Data Expert

Have a question? We'll get back to you promptly.